Birchview Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Birchview Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$1.03M	–	62
2022 Q3	$1.03M	Hold	20,000	–	–	0.73%	27
2022 Q2	$496K	Hold	20,000	–	–	0.36%	37
2022 Q1	$501K	Hold	20,000	–	–	0.36%	41
2021 Q4	$728K	Sell	20,000 -5,000	-20%	-$176K	0.47%	34
2021 Q3	$428K	Sell	25,000 -5,000	-17%	-$77.9K	0.29%	44
2021 Q2	$402K	Hold	30,000	–	–	0.24%	49
2021 Q1	$1.54M	Hold	30,000	–	–	0.91%	19
2020 Q4	$1.86M	Hold	30,000	–	–	1.07%	17
2020 Q3	$1.64M	Hold	30,000	–	–	1.1%	18
2020 Q2	$1.73M	Hold	30,000	–	–	1.04%	17
2020 Q1	$1.21M	Buy	30,000 +5,000	+20%	+$212K	1.07%	16
2019 Q4	$989K	Buy	+25,000	New	+$439K	0.72%	24

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Birchview Capital's CCXI Position: Q4 2022 in Review

Birchview Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 20,000 shares — an estimated $1.03M sold.

Birchview Capital first reported a position in CCXI in Q4 2019 and held it in 12 quarters. The position peaked at $1.86M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Birchview Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Birchview Capital sold 20,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.03M.
Birchview Capital first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 12 quarters.
Birchview Capital's ChemoCentryx, Inc. position peaked at $1.86M in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Birchview Capital's 13F filing for Q4 2022, filed 3 Feb 2023.